Alternatives
Alternatives to Cangrelor 50 mg powder for injection
1 other presentations of Cangrelor 50 mg powder for injection
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Cangrelor), strength (50 mg) and dosage form (powder for injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Cangrelor 50 mg powder for injectionThis pageIntravenous | — | US FDA | 10 vials | Cangrelor for injection is supplied as a sterile lyophilized powder in single-dose 10 mL vials. • NDC # 68083-412-01: 10 mL vial containing 50 mg Cangrelor • NDC # 68083-412-10: 10 count of 10 mL vials containing 50 mg Cangrelor Vials of Cangrelor for injection should be stored at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F). | On request | — | Available on request |
| Kengreal 50 mg powder for injectionIntravenous | Chiesi | US FDA | 10 vials | NDC # 10122-620-01: 10 mL vial containing 50 mg cangrelor NDC # 10122-620-10: 10 count of 10 mL vials containing 50 mg cangrelor Vials of KENGREAL should be stored at USP Controlled Room Temperature, [20°C to 25°C (68°F to 77°F) with excursions between 15°C and 30°C (59°F and 86°F) permitted]. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Cangrelor 50 mg powder for injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.